Several lines of clinical evidence have clearly shown that hyperinsulinemia is an independent risk factor for the development of atherosclerosis (1) (2) (3) . It has been proposed that insulin may have an important role in the pathogenesis of atherosclerosis (4) , although the data from in vitro experiments show that insulin acts as both an anti-atherogenic and atherogenic hormone (5, 6) . Previously, we observed that the hyperinsulinemic state caused by high fructose diet induced the production of superoxide anion and decreased nitric oxide production, resulting in the activation of the transcription factor NF-B and expression of its target genes in the cardiovascular tissues of rats (7) . The activation of NF-B is reported to stimulate the expression of inflammatory genes found in atheromatous lesions such as monocyte chemoattractant protein-1 (MCP-1) 1 and vascular cell adhesion molecule-1 (8, 9) . Therefore, the activation of NF-B in the vascular tissues in the hyperinsulinemic state may affect the pathogenesis of atherosclerotic lesions. Although the increased production of reactive oxygen species is one possible mechanism, how the hyperinsulinemic state activates the NF-B in cardiovascular tissues is still unknown. In addition, recent clinical studies have shown that levels of C-reactive protein as well as fibrinogen, in vivo signs of inflammation, are elevated in patients with hyperinsulinemia (10) , suggesting that inflammatory responses are also induced in the liver of hyperinsulinemic patients.
Insulin activates both the Ras/mitogen-activated protein kinase (MAPK) pathway and phosphatidylinositol 3-kinase (PI3K) pathway in many insulin-sensitive tissues or cells (11) . Previously, we showed that, in vascular smooth muscle cells (VSMCs), insulin at 1-10 nM concentration preferentially activates the PI3K pathway rather than the MAPK pathway resulting in stimulated amino acid uptake but not thymidine incorporation into DNA (12, 13) . These results indicate that the activation of PI3K does not directly stimulate cell proliferation at these insulin concentrations. Recently, it was reported that the activation of Akt, a serine/threonine kinase, downstream of the PI3K pathway stimulates the transcription factor NF-B through the activation of inhibitor of kappa B (IB) kinase in U293 cells (14, 15) . Thus, insulin may stimulate NF-B through activating PI3K and Akt and may play a role in the induction of proinflammatory gene expression and promotion of the inflammatory process in vascular tissues. Among the inflammatory processes found in an atheromatous lesion, the initial event is recruitment of monocytes to the lesion (16) . Monocyte chemoattractant protein-1 (MCP-1) plays a key role in the recruitment of monocytes (17) . In fact, strong expression of MCP-1 protein is observed in the human atherosclerotic lesion (18) and the selective knock-out of CCR2, the receptor of MCP-1, prevents the initiation of the atherosclerotic process in vivo (19) . Similar to other proinflammatory genes, the expression of MCP-1 is also regulated transcriptionally under the control of NF-B in human and rat cells (20, 21) .
In the present study, to elucidate the role of the activation of PI3K in the inflammatory gene expression elicited through possible activation of NF-B in VSMCs, we continuously increased the PI3K activity in cultured VSMCs using the recombinant adenovirus expressing membrane-targeted PI3K (p110CAAX). As previously reported (22) , the specific activation of PI3K mimics insulin activation. This technique allows us to study the direct effect of the activation of PI3K on the gene expression in VSMCs and the mechanisms by which it regulates proinflammatory gene expression in VSMCs. Unexpectedly, our study showed that the continuous activation of PI3K by the overexpression of p110CAAX increased the MCP-1 gene expression without activating NF-B in VSMCs. Here, we report the molecular mechanisms regulating MCP-1 gene expression in VSMCs by insulin or a direct activation of PI3K through activating CCAAT/enhancer binding proteins (C/ EBPs) but not NF-B.
EXPERIMENTAL PROCEDURES
Materials-Porcine insulin was kindly provided by Eli Lilly & Co. (Indianapolis, IN) . DMEM and FCS were purchased from Invitrogen (Grand Island, NY). Recombinant rat TNF-␣ was from Genzyme, Inc. (Cambridge, MA). Phospho-specific Akt antibody, phospho-specific glycogen synthase kinase 3 (GSK3) antibody, antibody to phospho-specific extracellular signal-regulated kinases (ERKs), phospho-specific p38 kinase antibody, and IB-␣ antibody were from New England BioLabs, Inc. (Beverly, MA). Phospho-specific c-Jun N-terminal kinase (JNK) antibody was from Promega (Madison, WI). Antibodies to C/EBP-␣, -␤, and -␦ were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). XAR-5 film was purchased from Eastman Kodak Co. (Rochester, NY).
[␥- Cell Culture-VSMCs were isolated from the aortas of male SpragueDawley rats (200 -300 g) by enzymatic digestion, and they were maintained in DMEM supplemented with 10% FCS, 80 units/ml penicillin G, and 80 g/ml streptomycin in 100-mm plates (5 ϫ 10 6 cells per dish) as described previously (13) . Culture media were changed every third day, and VSMCs were used between the 4th and 15th passages. Cell growth was arrested for 16 -48 h in DMEM supplemented with 1% FCS before the experiments.
The Ad-E1A-transformed human embryonic kidney cell line U293 was cultured in DMEM high glucose medium containing 80 units/ml penicillin G, 80 g/ml streptomycin, and 10% FCS.
Cell Treatment-VSMCs were infected at 50 m.o.i. for 1 h with stocks of either a control recombinant adenovirus (Ad5-LacZ) containing the cytomegalovirus promoter, pUC 18 polylinker, and a fragment of the SV40 genome, or the recombinant adenovirus Ad5-p110CAAX (22) . Infected cells were incubated for 48 h at 37°C in DMEM with 10% FCS, followed by incubation in the starvation medium required for the assay. The efficiency of adenovirus-mediated gene transfer was ϳ90%, as measured by ␤-galactosidase staining. The survival of the VSMCs was unaffected by the incubation of cells with the different adenovirus constructs, because the total cell protein remained the same in infected or uninfected cells.
Western Blot Analysis-VSMCs, infected with Ad5-p110CAAX or Ad5-LacZ, were starved for 16 h in DMEM with 1% FCS. The cells were stimulated with 1-100 nM insulin for 5-20 min at 37°C and lysed in a solubilizing buffer containing 20 mM Tris (pH 7.5), 1 mM EDTA, 140 mM NaCl, 1% Nonidet P-40, 50 units/ml aprotinin, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, and 50 mM NaF for 10 min at 4°C. The cell lysates were centrifuged to remove insoluble materials. For Western blot analysis, whole-cell lysates (50 g of protein per lane) were denatured by boiling in Laemmli sample buffer containing 100 mM DTT and resolved by SDS-PAGE. Gels were transferred to nitrocellulose by electroblotting in Towbin buffer containing 20% methanol. For immunoblotting, membranes were blocked and probed with the specified antibodies. Blots were then incubated with horseradish peroxidaselinked second antibody followed by chemiluminescence detection, according to the manufacturer's (PerkinElmer Life Sciences) instructions.
RNA Extraction and Northern Blot Analysis-The Ad5-p110CAAX or Ad5-LacZ-infected cells were stimulated and lysed in TRIzol reagent (Invitrogen). After chloroform extraction, total RNA was isolated by isopropanol precipitation. Total RNA (30 g) was denatured and electrophoresed on a 1% agarose-2% formaldehyde gel and blotted onto a Nytran N membrane. A 1.1-kb NcoI fragment of C/EBP-␣, 0.4-kb NcoI fragment of C/EBP-␤, or 1.0-kb EcoRI-BamHI fragment of C/EBP-␦ was used as a probe. Full-length bovine p110␣ cDNA, 0.5-kb rat MCP-1 cDNA, 0.2-kb rat plasminogen activator inhibitor (PAI-1) cDNA, 0.8-kb rat tissue factor cDNA, and 1.0-kb rat glyceraldehyde-3-phosphate dehydrogenase cDNA were labeled with [␣-32 P]dCTP by random priming. Then the membrane was incubated with specific probes, washed, and visualized by autoradiography. All the quantitative data were corrected by the intensity of glyceraldehyde-3-phosphate dehydrogenase mRNA signals.
Electrophoretic Mobility Shift Assay-Nuclear extracts were prepared from VSMCs according to the method described by Dignam et al. (23) . Cytoplasmic extracts from VSMCs were used for measurement of IB-␣ protein content by Western blot analysis. After protein concentrations were determined using Bio-Rad Protein Assay Reagent (BioRad Laboratories, Hercules, CA), the nuclear extracts were divided into small aliquots, quickly frozen in liquid nitrogen, and stored at Ϫ80°C. For electrophoretic mobility shift assay (EMSA), double-stranded oligodeoxynucleotide probes for the two consensus sequences of NF-B binding sites of rat MCP-1 gene promoter, Ϫ2291 bp to Ϫ2273 bp (5Ј-GTCTGGGAACTTCCAATGC-3Ј) (A site) and Ϫ2265 bp to Ϫ2250 bp (5Ј-GAATGGGAATTTCCAC-3Ј) (B site) were generated. The doublestranded oligodeoxynucleotide probes for C/EBP were generated by annealing two complementary oligodeoxynucleotides corresponding to the nucleotide sequence spanning the 5Ј-flanking region of the rat MCP-1 gene, Ϫ2596 bp to Ϫ2572 bp (5Ј-TATGGCATTGACCAAAGTC-CATGGG-3Ј) (A site) and Ϫ3123 bp to Ϫ3099 bp (5Ј-GTCGATGCTGAC-CAAACAATCATTG-3Ј) (B site). The NF-B, activator protein (AP-1), and C/EBP probes were end-labeled with [␥-
32 P]ATP using T 4 -polynucleotide kinase. Nuclear extracts (5 g) were incubated with 1.0 ϫ 10 5 cpm of the labeled NF-B or C/EBP probe for 30 min at room temperature in a 20-l binding buffer containing 10 mM HEPES (pH 7.9), 50 mM NaCl, 1 mM DTT, 10% glycerol, 0.5 mM EDTA, and 75 g/ml of poly(dI-dC)/(dI-dC) (Amersham Pharmacia Biotech., Buckinghamshire, UK). For competition, a 100-fold molar excess of unlabeled probe was added to the nuclear extracts. Then, all reaction mixtures were analyzed by 6% polyacrylamide gel electrophoresis in 0.25ϫ TBE (45 mM Tris borate, 1 mM EDTA), and the gel was dried and visualized by autoradiography.
Contraction of Plasmids-The 5Ј-flanking region of rat MCP-1 from Ϫ3554 bp to ϩ54 bp was amplified using rat genomic DNA by PCR with the sense primer, 5Ј-CTCAAAGGTGCTGCAGAGTTACTT-3Ј, and antisense primer, 5Ј-TGCATAGTGGTGGAGGAAGAGAGATCTGG-3Ј, as previously reported (21) . The resultant amplicon was gel-purified, inserted into pCR2.1-TOPO vector (Invitrogen, Inc., Carlsbad, CA), digested with KpnI/BglII, and inserted into KpnI/BglII-linearized pGL3-basic to form pGL3-MCP1 (MCP1-3.6 kb). The 2270-bp rat MCP-1 promoter region between Ϫ2217 bp and ϩ54 bp was cloned by enzyme digestion with PvuII (MCP1-2.3 kb), and the 2581-bp rat MCP-1 promoter region between Ϫ2528 bp and ϩ54 bp was cloned from MCP1-3.6 kb deleted with Exonuclease III and Mung Bean nuclease (Takara, Shiga, Japan) (MCP1-2.6 kb).
Mutagenesis-Site-directed mutagenesis was performed on the putative NF-B or C/EBP binding sites in the distal enhancer region of the MCP-1 3.6-kb plasmid using the QuikChange site-directed mutagenesis kit (Stratagene, Inc., La Jolla, CA) according to the manufacturer's instructions. The oligonucleotides 5Ј-CTGAAGGGTCTGGGAACTcggAATGCTGCCTC-3Ј (lower-case and italic letters represent mutated nucleotides) and 5Ј-GCCTCAGAATGGccATTTCCACACTCTTATCC-3Ј were used to obtain mutated NF-B binding sites A and B (MCP1-NFBMAB). The two putative C/EBP binding sites in the distal enhancer region were revealed by nucleotide sequence analysis and mutated using the oligonucleotides 5Ј-GGGAAGGTATGGCAgactagtcAGT-CCATGGGCAG-3Ј and 5Ј-GCCCAAAGTCGATGgactagtcACAATCATT-GGAACC-3Ј to form the C/EBP construct MCP1-CEBPMAB.
Cell Transfection and Luciferase Assay-Rat VSMCs were seeded on 12-well cell culture plates. After 24 h of incubation, the cells were 60 -80% confluent. The VSMCs were cotransfected with 0.2 g of luciferase expression plasmid and 0.05 g of PRL-TK plasmid as normalization reference for transfection efficiency, and 0.75 g of each expression plasmid using LipofectAMINE plus (Invitrogen, Rockville, MD) following the instructions for the reagent. After 48-h transfection, the cells were harvested. The Firefly and Renilla luciferase activities were determined by using a dual-luciferase reporter assay kit (Promega) with a signal detection duration of 30 s by a luminometer (Auto LUMIcounter Nu1422ES, Microtec, Tokyo, Japan).
Immunocytochemical Analysis-The cells were stained as described previously (24) . In brief, the cells were fixed for 2 h with 4% paraformaldehyde and washed for 2 days with PBS at 4°C. Then the cells were incubated with antibodies against C/EBP-␣, -␤, and -␥ diluted to 1:1000 in PBS containing 0.3% Triton X. The cells were further incubated with the species-specific secondary antibody conjugated to fluorescein isothiocyanate. The positive reaction was observed under a fluorescence microscope (Olympus IX70, Osaka, Japan), and the images were taken with a charge-coupled device camera (Cool SNAP/HQ, Nippon Roper Co., Osaka, Japan).
Statistical Analysis-The values are expressed as means Ϯ S.E., unless otherwise stated. The Tukey-Welsch step-down multiple comparison test was used to determine the significance of any differences among more than four groups. p Ͻ 0.05 was considered significant. incubated for 48 h at 37°C in DMEM with 10% FCS, followed by incubation in the starvation medium for 16 h. Western and Northern blots are representative of five independent experiments. A, mRNA expression of p110␣ was examined by Northern blot analysis. B, the level of phosphorylation of Akt or GSK3 was analyzed by Western blotting analysis with p-Akt (Ser-473) or p-GSK3 (Ser-9) antibody. The starved cells were incubated with or without 1 M wortmannin for 30 min and stimulated with or without 100 nM insulin for the indicated periods. C, the levels of phosphorylation of MAPKs were analyzed by Western blotting analysis with p-ERK, p-JNK, or p-p38 MAPK antibody. Starved cells were stimulated with or without 10 -100 nM insulin (Ins) or 100 nM angiotensin II (AII) for 10 min. D, the effect of the overexpression of p110CAAX on gene expression in VSMCs was investigated with Northern blot analysis. The starved cells were stimulated with or without 10% FCS for 4 h. E, the dose-dependent effect of the Ad5-p110CAAX on the induction of MCP-1 gene by the overexpression of p110CAAX in VSMCs was assessed by Northern blot analysis. F, the effect of overexpression of p110CAAX on plasminogen activator inhibitor-1 (PAI-1) or tissue factor gene expression in VSMCs assessed by Northern blot analysis is shown. the cells without stimulation (Fig. 1, A and B) . The effect of insulin on the MCP-1 gene expression was inhibited by 100 nM wortmannin, a PI3K inhibitor, indicating the involvement of PI3K in the induction of MCP-1 gene by insulin.
RESULTS

Insulin Induces MCP-1 Gene Expression in VSMCs-
Expression of p110CAAX in VSMCs-VSMCs were infected with recombinant adenovirus expressing either the membranetargeted p110CAAX or LacZ at 50 m.o.i. for 1 h, and mRNA expression of p110␣ was examined 48 h later. The mRNA band of the p110␣ was detected in the cells infected with Ad5-p110CAAX but not in cells infected with control adenovirus or cells without infection ( Fig. 2A) . To examine the activity of PI3K in the VSMCs overexpressing the membrane-targeted p110CAAX, the level of phosphorylation of Akt or GSK3, a serine/threonine kinase, downstream of PI3K was analyzed by Western blotting analysis with p-Akt (Ser-473) or p-GSK3 (Ser-9) antibodies. As shown in Fig. 2B , the overexpression of membrane-targeted p110CAAX in VSMCs resulted in increases in the phosphorylation of both Akt and GSK3 to the level comparable with that of 100 nM insulin stimulation. Pretreatment with 1 M wortmannin completely inhibited the phosphorylation induced by either p110CAAX expression or 100 nM insulin in VSMCs. As we previously reported (13) , in contrast to 100 nM angiotensin II, VSMCs incubated with 100 nM insulin for 10 min showed little phosphorylation of MAPKs such as ERK, JNK, and p38 MAPK assessed by Western blot analysis. Consistent with these results, the overexpression of p110CAAX in VSMCs did not increase the phosphorylation of these MAPKs (Fig. 2C) .
The effect of overexpression of p110CAAX on gene expression in VSMCs was investigated with Northern blot analysis. MCP-1 was induced at 10-to 15-fold of the control levels after the overexpression of p110CAAX (Fig. 2D) . The induction of the gene by the overexpression of p110CAAX in VSMCs was dosedependent (Fig. 2E) . However, neither PAI-1 nor tissue factor mRNAs were induced by the overexpression of p110CAAX in VSMCs (Fig. 2F) , indicating the specificity of MCP-1 gene expression by p110CAAX.
p110CAAX Expression and NF-B and AP-1 Activation-To confirm the increased MCP-1 gene expression through either NF-B or AP-1 activation, we examined the binding activity of NF-B and AP-1 in VSMCs overexpressed with p110CAAX using EMSA. As shown in Fig. 3 (A-C) , in contrast to the results of TNF-␣ or PMA stimulation, the overexpression of p110CAAX in VSMCs activated neither NF-B nor AP-1 in VSMCs. NF-B activity is regulated by the proteasomal degradation of IB protein in the cytosol. Therefore, the protein level of IB-␣ in cytoplasmic extracts was determined by Western blot analysis. The IB-␣ content was reduced at 30 min after TNF-␣ (10 ng/ml) stimulation. However, the overexpression of p110CAAX did not reduce the protein content of IB-␣ (Fig. 3D) .
p110CAAX Expression and MCP-1 Promoter Activity-To investigate the mechanism for the induction of the MCP-1 gene expression by the overexpression of p110CAAX in VSMCs, functional promoter analysis was performed by transfecting a luciferase transporter plasmid (pGL3) carrying the upstream 3.6 kb of the MCP-1 gene (Fig. 4A) . As shown in Fig. 4B , the overexpression of p110CAAX in VSMCs increased the MCP-1 promoter-driven luciferase activity by 2.9-fold compared with the cells infected with control plasmid (p Ͻ 0.01). It has been reported that two NF-B binding elements located between 2.3 and 2.6 kb upstream of the MCP-1 gene have a functional role for TNF-␣ or other cytokines of up-regulating the transcriptional activity (21) . However, significant reduction (p Ͻ 0.01) of the luciferase activity was observed when the upstream region of the MCP-1 gene was deleted to 2.6 kb, in which the NF-B binding elements exist. Further deletion up to 2.3 kb did not further decrease the p110CAAX-induced luciferase activity (Fig. 4B) . In addition, the induction of luciferase activity by the overexpression of p110CAAX in VSMCs was not affected by the mutation of NF-B binding elements (Fig. 4B) .
cis-Element-regulating MCP-1 Promoter Activity in Response to PI3K-To identify the cis-element regulating the MCP-1 promoter activity in response to the overexpression of p110CAAX in VSMCs, we searched the nucleotide sequence in the region between 2.6 and 3.6 kb upstream of the MCP-1 gene using a transcriptional factor data base (TFSEARCH: www.cbrc.jp/research/db/TFSEARCH.html) and examined whether the site was activated by continuous activation of PI3K using EMSA. We identified two binding sites for CCAAT/ enhancer binding protein (C/EBP) in this region (Fig. 5A) and found that the binding of C/EBP was up-regulated by the overexpression of p110CAAX in VSMCs (Fig. 5, B and C) . Furthermore, as shown in Fig. 5 (D and E) , the mutation of these C/EBP binding elements significantly decreased the p110CAAX-induced luciferase activity (p Ͻ 0.01) in VSMCs.
C/EBP-␤ and -␦ Trans-activate the MCP-1
Promoter-To estimate whether C/EBPs are capable of stimulating the MCP-1 promoter activity, we transiently cotransfected the expression plasmid containing cDNA of either C/EBP-␣, C/EBP-␤, or C/EBP-␦ with luciferase transporter plasmid (pGL3) carrying the upstream 3.6 kb of the MCP-1 gene. As shown in Fig. 6 , the overexpression of C/EBP-␤ or C/EBP-␦ in VSMCs increased luciferase activity by 6-to 7-fold (p Ͻ 0.01) of that of the control cells, whereas C/EBP-␣ did not significantly increase the promoter activity.
p110CAAX Expression and C/EBP Expression in the NucleiThe overexpression of p110CAAX in VSMCs increased mRNA expression of C/EBP-␤ by 1.6-fold (p Ͻ 0.05) and C/EBP-␦ by 2.6-fold (p Ͻ 0.01) as compared with that in cells infected with control virus but did not change C/EBP-␣ expression (Fig. 7,  A-C) . Additionally, the protein levels of C/EBP-␤ and C/EBP-␦ were increased in the nuclear extract of VSMCs with overexpressed p110CAAX as compared with the cells infected with control virus, by 2-fold (p Ͻ 0.01) and by 1.7-fold (p Ͻ 0.01), respectively (Fig. 8, A-C) . These results were also confirmed by immunocytochemical staining of the VSMCs with either C/EBP-␣, C/EBP-␤, or C/EBP-␦. The overexpression of p110CAAX increased the nuclear expression of C/EBP-␤ and C/EBP-␦ but not C/EBP-␣ (Fig. 9, A-C) .
Insulin Increases the Nuclear Expression of C/EBP-␤ and -␦-To evaluate the effects of insulin on C/EBP expression, we investigated the nuclear C/EBP expression in VSMCs using Western blot analysis. As shown in Fig. 10 , stimulation with 1-10 nM insulin dose-dependently increased the nuclear protein level of C/EBP-␤ by 1.3-to 1.4-fold and C/EBP-␦ by 1.6-to 2.0-fold over the basal level but did not affect C/EBP-␣.
DISCUSSION
In the present study, we found that the overexpression of p110CAAX in VSMCs activated the downstream of the PI3K signal pathway, such as Akt and GSK3, but not MAPKs. The specific and chronic activation of PI3K by the overexpression of p110CAAX as well as the stimulation with a near physiological dose of insulin induced gene expression of a proinflammatory cytokine, MCP-1, in VSMCs through increasing the nuclear expression of C/EBP-␤ and C/EBP-␦. These observations may provide a new concept for the pathophysiological role of PI3K activation for the enhancement of proinflammatory gene expression observed in the development of atheromatous lesions.
Although atherosclerosis has been considered to be the accumulation of lipids within the arterial wall, it has recently been emphasized that a series of inflammatory processes is involved in the development of the atherosclerotic lesion and the onset of acute coronary syndromes (25) . The initial step of the process is recruitment of monocytes to the lesion. In this process, the cytokine MCP-1 is thought to play a major role. Actually, in human atheromatous lesions, strong expression of MCP-1 is observed (18) . The induction of MCP-1 is one of the inflammatory responses regulated by many factors, including proinflammatory cytokines, hormones, lipopolysaccharide, and modified lipids (26) . The present study reveals that insulin is also a factor evoking the initial step of the inflammatory response in VSMCs. Recently, several lines of clinical evidence have supported the role of the hyperinsulinemic state in the development of atherosclerosis and the association of the insulin-resistant state with increased level of a marker of inflammation (27) . Our finding may suggest one of the molecular mechanisms by which hyperinsulinemia induces inflammatory process in the artery.
Most previous reports have shown that the induction of MCP-1 is regulated by transcription factor NF-B (28). Wang et al. (21) have shown that the activation of NF-B plays a key role in the induction of rat MCP-1 gene expression through its binding to the NF-B response elements located at Ϫ2280 bp and Ϫ2261 bp from the starting point of MCP-1 transcription. Interestingly, we found that insulin or activation of PI3K induced the MCP-1 gene expression in VSMCs without the activation of NF-B. We confirmed this finding in three experiments. First, in contrast to the effect of TNF-␣ stimulation, the activation of PI3K by overexpression of p110CAAX did not enhance the binding activity of NF-B based on the assessment of EMSA and the degradation of IB-␣. Furthermore, the activation of PI3K did not increase the luciferase activity of pGL3 plasmid carrying the 2.6-kb upstream region of MCP-1 gene, which contained NF-B response elements, and finally, the specific mutation of NF-B response elements at Ϫ2280 bp and Ϫ2261 bp did not affect the p110CAAX-induced luciferase activity of pGL3 plasmid carrying the 3.6-kb upstream region of MCP-1 gene. These observations clearly indicate that the activation of NF-B is not involved in the induction of promoter activity of MCP-1 by the overexpression of p110CAAX. We observed that the mutation of NF-B response elements decreased the promoter activities of MCP-1 in both cells with overexpression of p110CAAX and control plasmid, indicating that the NF-B response elements have a role in the basal promoter activity of the MCP-1 in VSMCs. Like NF-B, AP-1 and sequence-specific transcription factor (Sp1) were not involved in the induction of MCP-1 gene expression by the activation of PI3K as assessed by EMSA and luciferase assay (data not shown). We found that two C/EBP binding elements located at Ϫ2579 to Ϫ2591 bp and Ϫ3107 to Ϫ3118 bp from the starting point of MCP-1 transcription had a role in the gene expression of MCP-1 induced by the overexpression of p110CAAX. The involvement of the C/EBP binding elements was confirmed in our experiments showing that specific mutation of two C/EBP binding elements abolishes the enhancement of promoter activity of MCP-1 by the overexpression of p110CAAX. In addition, the result that the overexpression of C/EBP-␤ and C/EBP-␦ but not C/EBP-␣ increased the MCP-1 promoter activity also supports the involvement of C/EBP-␤ and C/EBP-␦ in the p110CAAX-induced MCP-1 promoter activity. A similar involvement of C/EBP in the induction of IL-6 and MCP-1 gene expression by lipopolysaccharide was reported in a lymphoblastic cell line (29) .
We observed that the overexpression of p110CAAX increased the nuclear expression of C/EBP-␤ and C/EBP-␦ using EMSA, Western blot analysis, and immunostaining of the cells with antibodies against C/EBPs. These results clearly indicate that the overexpression of p110CAAX facilitates the translocation of C/EBP-␤ from the perinuclear region to the nuclei while the mRNA contents of C/EBP-␤ and C/EBP-␦ were elevated by possible de novo synthesis. In addition, we found a marked increase in the mRNA expression of C/EBP-␦ but only a modest increase in the mRNA expression of C/EBP-␤ in the cells overexpressed with p110CAAX. In fact, the enhancement of the binding activity of C/EBP-␤ by a phosphorylation or dephosphorylation mechanism was reported (30, 31) . Hanlon et al. (32) reported that phosphorylation of C/EBP-␤ by ERK2 increased the interaction with serum response factor resulting in elevated c-fos promoter activity, although downstream effectors of PI3K such as Rac, Cdc42, and Akt did not have a role in regulating the interaction of C/EBP-␤ and serum response factor (32) . On the other hand, it is reported that growth hormone decreases the phosphorylation of C/EBP-␤ and enhances its activity through increasing the phosphorylation of Akt and GSK3 in 3T3 cells (33) . Although we did not measure the amount of phosphorylation of C/EBP-␤ in this study, considering that the overexpression of p110CAAX increased the phosphorylation of Akt and GSK3 while phosphorylation of MAPKs was not increased, the activation of PI3K by overexpression of p110CAAX may enhance the activity of C/EBP-␤ by modulating the Akt and GSK3 activities in VSMCs. This increase in the C/EBP-␤ activity might possibly induce the C/EBP-␦ expression (34) .
We found that insulin at 1-10 nM also increased the mRNA expression of MCP-1 as well as C/EBP-␤ and C/EBP-␦ expression in VSMCs. These effects of insulin were completely blocked in the presence of wortmannin, suggesting that the activation of PI3K played a key role in the gene regulation of MCP-1 and C/EBP-␤ and C/EBP-␦ by insulin. In addition, we found that the phosphorylation of Akt by insulin was not blocked by insulin-like growth factor-1 receptor antibody (data not shown), indicating that insulin activated the PI3K through the insulin receptor-insulin receptor substrates pathway in VSMCs. Because our findings, that insulin and activation of PI3K both regulate proinflammatory gene expressions, were obtained in cultured VSMCs, they do not necessarily indicate that PI3K and C/EBPs are activated in the hyperinsulinemic state in vivo. Jiang et al. (35) have shown that selective resistance of the PI3K pathway to insulin resulted in relative activation of MAPKs in the vascular tissues of genetic hyperinsulinemic Zucker fatty rats. We found, however, an elevation of phosphorylation of Akt in the vascular tissues from the Zucker fatty rats in the fasting state (data not shown). These results suggest that PI3K in the vascular tissues may be activated continuously by the chronic hyperinsulinemia found in the insulin-resistant state, although the acute response to insulin is blunted. Thus, the hyperinsulinemia in the insulin-resistant state may have a role in the development of atherosclerosis through activating the PI3K in VSMCs, although the role of insulin in atherogenesis has been a matter of debate for years (4, 6, 36) . We should, however, note that our present investigation was mainly done under culture condition where VSMCs were present alone. In the vascular tissues, VSMCs are always accompanied by endothelial cells. Because PI3K activates the endothelial nitric-oxide synthase (37) , insulin activates PI3K in VSMCs and increases NO production in endothelial cells at the same time in vascular tissue. It is reported that NO has antiatherogenic and anti-inflammatory actions (38) . In fact, inhibition of endothelial nitric-oxide synthase induced MCP-1 production and inflammatory response in cardiovascular tissues (39) . Interestingly, NO production was decreased in the insulin-resistant state in humans (40) and rat models (41) even in the presence of hyperinsulinemia. Thus, to clarify the role of PI3K activation in proinflammatory gene expression under in vivo condition, one should always evaluate NO production in endothelial cells, because it might affect proinflammatory gene expression profoundly in VSMCs.
In conclusion, the chronic activation of PI3K with the use of adenovirus-mediated overexpression of p110CAAX and stimulation with 1-10 nM insulin in VSMCs induced nuclear expression of C/EBP-␤ and C/EBP-␦, resulting in induction of MCP-1 gene expression. The involvement of C/EBP-␤ and C/EBP-␦ in the gene expression of various inflammatory cytokines other than MCP-1, such as IL-1␤, IL-6, IL-8, IL-12, and TNF-␣ (34, 42) , has been reported. Thus, our findings might indicate that activation of insulin signals in VSMCs promotes the inflammatory reaction leading to the development of atherosclerosis, although we need further investigation in vivo to explore the role of hyperinsulinemia in the induction of inflammatory response in various tissues, including vascular tissues.
